ADMA vs. NVDA
Compare and contrast key facts about ADMA Biologics, Inc. (ADMA) and NVIDIA Corporation (NVDA).
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: ADMA or NVDA.
Correlation
The correlation between ADMA and NVDA is 0.18, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.
Performance
ADMA vs. NVDA - Performance Comparison
Key characteristics
ADMA:
3.31
NVDA:
1.58
ADMA:
4.09
NVDA:
2.13
ADMA:
1.56
NVDA:
1.27
ADMA:
3.70
NVDA:
3.31
ADMA:
18.90
NVDA:
9.51
ADMA:
11.50%
NVDA:
9.43%
ADMA:
65.92%
NVDA:
56.83%
ADMA:
-91.28%
NVDA:
-89.73%
ADMA:
-27.19%
NVDA:
-21.93%
Fundamentals
ADMA:
$3.82B
NVDA:
$3.05T
ADMA:
$0.27
NVDA:
$2.44
ADMA:
59.81
NVDA:
49.21
ADMA:
0.00
NVDA:
0.86
ADMA:
$308.91M
NVDA:
$91.17B
ADMA:
$155.89M
NVDA:
$69.14B
ADMA:
$107.80M
NVDA:
$60.32B
Returns By Period
In the year-to-date period, ADMA achieves a -3.97% return, which is significantly higher than NVDA's -13.13% return. Over the past 10 years, ADMA has underperformed NVDA with an annualized return of 4.56%, while NVDA has yielded a comparatively higher 73.16% annualized return.
ADMA
-3.97%
-10.68%
45.75%
214.91%
32.27%
4.56%
NVDA
-13.13%
-19.25%
16.16%
76.37%
80.02%
73.16%
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Risk-Adjusted Performance
ADMA vs. NVDA — Risk-Adjusted Performance Rank
ADMA
NVDA
ADMA vs. NVDA - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for ADMA Biologics, Inc. (ADMA) and NVIDIA Corporation (NVDA). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Dividends
ADMA vs. NVDA - Dividend Comparison
ADMA has not paid dividends to shareholders, while NVDA's dividend yield for the trailing twelve months is around 0.02%.
| TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
ADMA ADMA Biologics, Inc. | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
NVDA NVIDIA Corporation | 0.02% | 0.02% | 0.03% | 0.11% | 0.05% | 0.12% | 0.27% | 0.46% | 0.29% | 0.45% | 1.20% | 1.70% |
Drawdowns
ADMA vs. NVDA - Drawdown Comparison
The maximum ADMA drawdown since its inception was -91.28%, roughly equal to the maximum NVDA drawdown of -89.73%. Use the drawdown chart below to compare losses from any high point for ADMA and NVDA. For additional features, visit the drawdowns tool.
Volatility
ADMA vs. NVDA - Volatility Comparison
The current volatility for ADMA Biologics, Inc. (ADMA) is 16.12%, while NVIDIA Corporation (NVDA) has a volatility of 25.16%. This indicates that ADMA experiences smaller price fluctuations and is considered to be less risky than NVDA based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Financials
ADMA vs. NVDA - Financials Comparison
This section allows you to compare key financial metrics between ADMA Biologics, Inc. and NVIDIA Corporation. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities